367 related articles for article (PubMed ID: 17538295)
1. Diffusion-weighted imaging of the prostate at 3 T for differentiation of malignant and benign tissue in transition and peripheral zones: preliminary results.
Kim CK; Park BK; Han JJ; Kang TW; Lee HM
J Comput Assist Tomogr; 2007; 31(3):449-54. PubMed ID: 17538295
[TBL] [Abstract][Full Text] [Related]
2. Value of diffusion-weighted imaging for the prediction of prostate cancer location at 3T using a phased-array coil: preliminary results.
Kim CK; Park BK; Lee HM; Kwon GY
Invest Radiol; 2007 Dec; 42(12):842-7. PubMed ID: 18007156
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.
Yoshizako T; Wada A; Hayashi T; Uchida K; Sumura M; Uchida N; Kitagaki H; Igawa M
Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184
[TBL] [Abstract][Full Text] [Related]
4. Diffusion-weighted imaging of normal and malignant prostate tissue at 3.0T.
Pickles MD; Gibbs P; Sreenivas M; Turnbull LW
J Magn Reson Imaging; 2006 Feb; 23(2):130-4. PubMed ID: 16374882
[TBL] [Abstract][Full Text] [Related]
5. In vivo measurement of the apparent diffusion coefficient in normal and malignant prostatic tissue using thin-slice echo-planar imaging.
Manenti G; Squillaci E; Di Roma M; Carlani M; Mancino S; Simonetti G
Radiol Med; 2006 Dec; 111(8):1124-33. PubMed ID: 17171522
[TBL] [Abstract][Full Text] [Related]
6. High-b-value diffusion-weighted imaging at 3 T to detect prostate cancer: comparisons between b values of 1,000 and 2,000 s/mm2.
Kim CK; Park BK; Kim B
AJR Am J Roentgenol; 2010 Jan; 194(1):W33-7. PubMed ID: 20028888
[TBL] [Abstract][Full Text] [Related]
7. Apparent diffusion coefficient values in peripheral and transition zones of the prostate: comparison between normal and malignant prostatic tissues and correlation with histologic grade.
Tamada T; Sone T; Jo Y; Toshimitsu S; Yamashita T; Yamamoto A; Tanimoto D; Ito K
J Magn Reson Imaging; 2008 Sep; 28(3):720-6. PubMed ID: 18777532
[TBL] [Abstract][Full Text] [Related]
8. Endorectal diffusion-weighted imaging in prostate cancer to differentiate malignant and benign peripheral zone tissue.
Hosseinzadeh K; Schwarz SD
J Magn Reson Imaging; 2004 Oct; 20(4):654-61. PubMed ID: 15390142
[TBL] [Abstract][Full Text] [Related]
9. Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver.
Xu PJ; Yan FH; Wang JH; Shan Y; Ji Y; Chen CZ
J Comput Assist Tomogr; 2010 Jul; 34(4):506-12. PubMed ID: 20657216
[TBL] [Abstract][Full Text] [Related]
10. Diffusion tensor magnetic resonance imaging of prostate cancer.
Manenti G; Carlani M; Mancino S; Colangelo V; Di Roma M; Squillaci E; Simonetti G
Invest Radiol; 2007 Jun; 42(6):412-9. PubMed ID: 17507813
[TBL] [Abstract][Full Text] [Related]
11. Diffusion-weighted magnetic resonance imaging of breast lesions: first experiences at 3 T.
Lo GG; Ai V; Chan JK; Li KW; Cheung PS; Wong TT; Ma M; Lee R; Chien D
J Comput Assist Tomogr; 2009; 33(1):63-9. PubMed ID: 19188787
[TBL] [Abstract][Full Text] [Related]
12. [Diffusion weighted MRI helps evaluate angiogenesis and vascular endothelial growth factor expression in prostate cancer].
Liu JG; Wang B; Wang XZ; Niu QL; Zhang Q
Zhonghua Nan Ke Xue; 2009 May; 15(5):403-8. PubMed ID: 19514550
[TBL] [Abstract][Full Text] [Related]
13. Prostate cancer detection with multi-parametric MRI: logistic regression analysis of quantitative T2, diffusion-weighted imaging, and dynamic contrast-enhanced MRI.
Langer DL; van der Kwast TH; Evans AJ; Trachtenberg J; Wilson BC; Haider MA
J Magn Reson Imaging; 2009 Aug; 30(2):327-34. PubMed ID: 19629981
[TBL] [Abstract][Full Text] [Related]
14. [Comparative study on clinical and pathological changes of liver fibrosis with diffusion-weighted imaging].
Zhou ML; Yan FH; Xu PJ; Chen CZ; Shen JZ; Li RC; Ji Y; Shi JY
Zhonghua Yi Xue Za Zhi; 2009 Jul; 89(25):1757-61. PubMed ID: 19862980
[TBL] [Abstract][Full Text] [Related]
15. Diffusion-weighted imaging in normal prostate and differential diagnosis of prostate diseases.
Ren J; Huan Y; Wang H; Zhao H; Ge Y; Chang Y; Liu Y
Abdom Imaging; 2008; 33(6):724-8. PubMed ID: 18219519
[TBL] [Abstract][Full Text] [Related]
16. Prostate cancer detection: comparison of T2-weighted imaging, diffusion-weighted imaging, proton magnetic resonance spectroscopic imaging, and the three techniques combined.
Chen M; Dang HD; Wang JY; Zhou C; Li SY; Wang WC; Zhao WF; Yang ZH; Zhong CY; Li GZ
Acta Radiol; 2008 Jun; 49(5):602-10. PubMed ID: 18568549
[TBL] [Abstract][Full Text] [Related]
17. Correlation of diffusion-weighted magnetic resonance data with cellularity in prostate cancer.
Zelhof B; Pickles M; Liney G; Gibbs P; Rodrigues G; Kraus S; Turnbull L
BJU Int; 2009 Apr; 103(7):883-8. PubMed ID: 19007373
[TBL] [Abstract][Full Text] [Related]
18. Value of diffusion-weighted MR imaging in the differentiation between benign and malignant cervical lymph nodes.
Holzapfel K; Duetsch S; Fauser C; Eiber M; Rummeny EJ; Gaa J
Eur J Radiol; 2009 Dec; 72(3):381-7. PubMed ID: 18995981
[TBL] [Abstract][Full Text] [Related]
19. [Diffusion weighted imaging: its diagnostic and differential value for prostate cancer].
Shi H; Ding HY
Zhonghua Nan Ke Xue; 2007 Jul; 13(7):605-9. PubMed ID: 17725302
[TBL] [Abstract][Full Text] [Related]
20. Diffusion-weighted imaging of prostate cancer: correlation between apparent diffusion coefficient values and tumor proliferation.
Wang XZ; Wang B; Gao ZQ; Liu JG; Liu ZQ; Niu QL; Sun ZK; Yuan YX
J Magn Reson Imaging; 2009 Jun; 29(6):1360-6. PubMed ID: 19472393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]